|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
47,900,000 |
Market
Cap: |
51.73(M) |
Last
Volume: |
82,329 |
Avg
Vol: |
368,268 |
52
Week Range: |
$1.04 - $2.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P SMALLCAP 600 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Enzo Biochem is a diagnostics, clinical lab, and life sciences company. Co.'s operating segments include: Enzo Clinical Lab, which is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies; Enzo Life Sciences, which manufactures, develops and markets products and tools for clinical research, drug development and bioscience research customers worldwide; Enzo Therapeutics, which is a biopharmaceutical venture that has developed multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, various of which are derived from the work of Enzo Life Sciences.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
284,800 |
Total Buy Value |
$0 |
$0 |
$0 |
$580,670 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
10 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-21 |
2023-12-19 |
2023-06-20 |
2022-06-20 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2018-01-17 |
4 |
D |
$7.75 |
$112,639 |
D/D |
(14,534) |
1,838,668 |
|
- |
|
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2018-01-17 |
4 |
S |
$7.75 |
$108,500 |
D/D |
(14,000) |
1,853,202 |
|
- |
|
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2018-01-17 |
4 |
OE |
$2.88 |
$110,894 |
D/D |
38,505 |
1,867,202 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2018-01-17 |
4 |
D |
$7.75 |
$90,102 |
D/D |
(11,626) |
1,290,485 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2018-01-17 |
4 |
S |
$7.75 |
$85,250 |
D/D |
(11,000) |
1,302,111 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2018-01-17 |
4 |
OE |
$2.88 |
$88,710 |
D/D |
30,802 |
1,313,111 |
|
- |
|
Bortz Gregory M. |
Director |
|
2017-10-31 |
4 |
S |
$9.82 |
$412,489 |
D/D |
(42,005) |
250,870 |
|
- |
|
Bortz Gregory M. |
Director |
|
2017-10-31 |
4 |
OE |
$2.88 |
$171,230 |
D/D |
59,455 |
292,875 |
|
- |
|
Perlysky Dov |
Director |
|
2017-10-31 |
4 |
S |
$9.81 |
$412,020 |
D/D |
(42,000) |
642,237 |
|
- |
|
Perlysky Dov |
Director |
|
2017-10-31 |
4 |
OE |
$2.88 |
$171,230 |
D/D |
59,455 |
684,237 |
|
- |
|
Obrien James Michael |
EVP of Finance |
|
2017-10-27 |
4 |
S |
$10.28 |
$235,062 |
D/D |
(22,866) |
28,187 |
|
- |
|
Obrien James Michael |
EVP of Finance |
|
2017-10-27 |
4 |
OE |
$2.75 |
$81,624 |
D/D |
22,866 |
51,053 |
|
- |
|
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2017-10-25 |
4 |
D |
$10.09 |
$477,277 |
D/D |
(47,302) |
1,918,771 |
|
- |
|
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2017-10-25 |
4 |
S |
$10.09 |
$730,526 |
D/D |
(72,401) |
1,966,073 |
|
- |
|
Rabbani Elazar |
CEO, Chn. of the Brd. and Sec. |
|
2017-10-25 |
4 |
OE |
$3.00 |
$477,273 |
D/D |
159,091 |
2,038,474 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2017-10-25 |
4 |
D |
$10.11 |
$338,169 |
D/D |
(33,449) |
1,335,792 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2017-10-25 |
4 |
S |
$10.11 |
$547,214 |
D/D |
(54,126) |
1,369,241 |
|
- |
|
Weiner Barry W |
President, CFO, Treasurer, PAO |
|
2017-10-25 |
4 |
OE |
$3.00 |
$337,500 |
D/D |
112,500 |
1,423,367 |
|
- |
|
Obrien James Michael |
EVP of Finance |
|
2017-06-13 |
4 |
S |
$10.13 |
$160,054 |
D/D |
(15,800) |
15,800 |
|
- |
|
Kasten Bernard L |
Director |
|
2016-03-11 |
4 |
S |
$4.39 |
$44,271 |
D/D |
(10,054) |
0 |
|
- |
|
Kasten Bernard L |
Director |
|
2016-03-10 |
4 |
S |
$3.47 |
$115,554 |
D/D |
(30,228) |
10,054 |
|
- |
|
Kasten Bernard L |
Director |
|
2016-01-21 |
4 |
S |
$4.66 |
$11,640 |
D/D |
(2,500) |
40,282 |
|
- |
|
Perlysky Dov |
Director |
|
2015-01-01 |
4 |
A |
$0.00 |
$0 |
I/I |
42,798 |
40,872 |
|
- |
|
Perlysky Dov |
Director |
|
2015-01-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(416,589) |
109,237 |
|
- |
|
Kasten Bernard L |
Director |
|
2014-10-24 |
4 |
S |
$4.93 |
$61,780 |
D/D |
(12,500) |
42,782 |
|
- |
|
264 Records found
|
|
Page 4 of 11 |
|
|